Cargando…
Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society for Cell & Gene Therapy. Published by Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171026/ http://dx.doi.org/10.1016/S1465-3249(23)00242-6 |
| _version_ | 1785039343867396096 |
|---|---|
| author | Khan, S. English, S. Hodgins, S. Lalu, M. Watpool, I. Champagne, J. Freund, D. Möbius, M. Alexander Rüdiger, M. Fergusson, D. Thébaud, B. Stewart, D.J. Courtman, D.W. |
| author_facet | Khan, S. English, S. Hodgins, S. Lalu, M. Watpool, I. Champagne, J. Freund, D. Möbius, M. Alexander Rüdiger, M. Fergusson, D. Thébaud, B. Stewart, D.J. Courtman, D.W. |
| author_sort | Khan, S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10171026 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | International Society for Cell & Gene Therapy. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101710262023-05-10 Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL Khan, S. English, S. Hodgins, S. Lalu, M. Watpool, I. Champagne, J. Freund, D. Möbius, M. Alexander Rüdiger, M. Fergusson, D. Thébaud, B. Stewart, D.J. Courtman, D.W. Cytotherapy POSTER ABSTRACTS: Mesenchymal Stem/Stromal Cells International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2023-05 2023-05-10 /pmc/articles/PMC10171026/ http://dx.doi.org/10.1016/S1465-3249(23)00242-6 Text en Copyright © 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | POSTER ABSTRACTS: Mesenchymal Stem/Stromal Cells Khan, S. English, S. Hodgins, S. Lalu, M. Watpool, I. Champagne, J. Freund, D. Möbius, M. Alexander Rüdiger, M. Fergusson, D. Thébaud, B. Stewart, D.J. Courtman, D.W. Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL |
| title | Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL |
| title_full | Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL |
| title_fullStr | Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL |
| title_full_unstemmed | Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL |
| title_short | Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL |
| title_sort | mesenchymal stem/stromal cells: on demand manufacturing strategy to deliver multiple doses of freshly cultured umbilical cord derived mscs in the cellular immuno-therapy for covid-19 related ards clinical trial |
| topic | POSTER ABSTRACTS: Mesenchymal Stem/Stromal Cells |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171026/ http://dx.doi.org/10.1016/S1465-3249(23)00242-6 |
| work_keys_str_mv | AT khans mesenchymalstemstromalcellsondemandmanufacturingstrategytodelivermultipledosesoffreshlyculturedumbilicalcordderivedmscsinthecellularimmunotherapyforcovid19relatedardsclinicaltrial AT englishs mesenchymalstemstromalcellsondemandmanufacturingstrategytodelivermultipledosesoffreshlyculturedumbilicalcordderivedmscsinthecellularimmunotherapyforcovid19relatedardsclinicaltrial AT hodginss mesenchymalstemstromalcellsondemandmanufacturingstrategytodelivermultipledosesoffreshlyculturedumbilicalcordderivedmscsinthecellularimmunotherapyforcovid19relatedardsclinicaltrial AT lalum mesenchymalstemstromalcellsondemandmanufacturingstrategytodelivermultipledosesoffreshlyculturedumbilicalcordderivedmscsinthecellularimmunotherapyforcovid19relatedardsclinicaltrial AT watpooli mesenchymalstemstromalcellsondemandmanufacturingstrategytodelivermultipledosesoffreshlyculturedumbilicalcordderivedmscsinthecellularimmunotherapyforcovid19relatedardsclinicaltrial AT champagnej mesenchymalstemstromalcellsondemandmanufacturingstrategytodelivermultipledosesoffreshlyculturedumbilicalcordderivedmscsinthecellularimmunotherapyforcovid19relatedardsclinicaltrial AT freundd mesenchymalstemstromalcellsondemandmanufacturingstrategytodelivermultipledosesoffreshlyculturedumbilicalcordderivedmscsinthecellularimmunotherapyforcovid19relatedardsclinicaltrial AT mobiusmalexander mesenchymalstemstromalcellsondemandmanufacturingstrategytodelivermultipledosesoffreshlyculturedumbilicalcordderivedmscsinthecellularimmunotherapyforcovid19relatedardsclinicaltrial AT rudigerm mesenchymalstemstromalcellsondemandmanufacturingstrategytodelivermultipledosesoffreshlyculturedumbilicalcordderivedmscsinthecellularimmunotherapyforcovid19relatedardsclinicaltrial AT fergussond mesenchymalstemstromalcellsondemandmanufacturingstrategytodelivermultipledosesoffreshlyculturedumbilicalcordderivedmscsinthecellularimmunotherapyforcovid19relatedardsclinicaltrial AT thebaudb mesenchymalstemstromalcellsondemandmanufacturingstrategytodelivermultipledosesoffreshlyculturedumbilicalcordderivedmscsinthecellularimmunotherapyforcovid19relatedardsclinicaltrial AT stewartdj mesenchymalstemstromalcellsondemandmanufacturingstrategytodelivermultipledosesoffreshlyculturedumbilicalcordderivedmscsinthecellularimmunotherapyforcovid19relatedardsclinicaltrial AT courtmandw mesenchymalstemstromalcellsondemandmanufacturingstrategytodelivermultipledosesoffreshlyculturedumbilicalcordderivedmscsinthecellularimmunotherapyforcovid19relatedardsclinicaltrial |